| Literature DB >> 9187208 |
E Maury1, V Ioos, B Lepecq, B Guidet, G Offenstadt.
Abstract
Lactic acidosis previously has been reported during treatment of asthma with beta-2 agonists. However, this metabolic disturbance never had any clinical consequence. We report a case of a patient with asthma in whom beta-2 agonist administration increased dyspnea by metabolic acidosis due to a sharp increase in lactate levels (hyperlactatemia) and led to inappropriate intensification of bronchodilator therapy.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9187208 DOI： 10.1378/chest.111.6.1766
Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410